Notable Analyst Rating Changes 9/22: (HOLX) (GSK) (MTZ) Upgraded; (OUTR) (YHOO) (INVN) Downgraded
Tweet Send to a Friend
UPGRADES
Piper Jaffray raises Hologic (Nasdaq: HOLX) from Neutral to Overweight and moves its price target from $28 to $32 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Jaffray raises Hologic (Nasdaq: HOLX) from Neutral to Overweight and moves its price target from $28 to $32 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE